Biosortia Microbiomics to Present at Biotech Showcase™ 2023 Biosortia’s proven technology obtains nature’s previously inaccessible drug-like small molecules for treatments and cures

Coffee Table Science

Don’t start big. Start small and continue small, and it will add up to massive. How steady improvement can also be a breakthrough

Human Microbiome Market (4th Edition): Focus on Therapeutics, Diagnostics and Fecal Microbiota Therapy By L Vijay, November 23, 2022. The human microbiome remained a largely unexplored area until 2007 when the Human Microbiome Project (HMP) was initiated. The project was undertaken to understand the concept of core human microbiome and its compatibility with the host

The Untapped Potential of Microbiome Mining in Drug Discovery and Precision Medicine By Ross Youngs, November 17, 2022. Through the innovative practice of microbiome mining, scientists and researchers will be able to harvest and study microbiome molecules at an industrial scale for the first time. Life science is on the verge of ushering in the

URI Pharmacy study seeks to identify new toxins in algal blooms Assistant Professor Matthew Bertin’s study funded by $400,000 federal grant focuses on freshwater lakes, rivers By Patrick Luce, November 14, 2022. KINGSTON, R.I. — Nov. 14, 2022 — Bacterial algal blooms and the toxins they produce are a persistent problem in freshwater lakes and

I, Microbiome: A Secret to a Healthy and Balanced Human Body November 03, 2022. Vladimir Jakovljevic. Thank you for including Industrial Scale Microbiome Mining and Biosortia in your new book. Biosortia is excited about the microbiome and the opportunities this virtually unexplored space will deliver to humanity. Therapeutics, agriculture, sustainability, longevity, advanced energy, carbon capture,